No. 12-2023, December 2023
Index
- A Summary of Comments on the 2023 Draft Merger Guidelines
- Managing Document Submissions Under the FTC and DOJ's Proposed HSR Filing Requirements
- Most-Favored Entry Clauses in Drug-Patent Litigation Settlements: A Reply to Drake and McGuire (2022)
- What California Can Teach Us About a World Without Non-Competes